Anaptysbio (ANAB) Preferred Dividend Payments (2016)

Anaptysbio's (ANAB) quarterly Preferred Dividend Payments came in at $2.1 million in Q2 2016.

Anaptysbio (ANAB) Preferred Dividend Payments (2016) Analysis & Trends

Anaptysbio (ANAB) has 1 years of Preferred Dividend Payments data on file, last reported at $2.1 million in Q2 2016.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $2.1 million in Q2 2016, while the trailing twelve-month figure through Sep 2017 was $2.1 million (changed N/A YoY) and the FY2024 annual result came in at -$82000.0, down 46.43% from the prior year.
Preferred Dividend Payments was little changed at $2.1 million in Q2 2016.
In the past five years, Preferred Dividend Payments ranged from a high of $2.1 million in Q2 2016 to a low of $2.1 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Anaptysbio	1.70 Bn	1.41 Bn	-	-

Download Data

Date	Value
Jun 30, 2016	2.14 Mn